The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TrilynX: A phase 3 trial of xevinapant and concurrent chemoradiation for locally advanced head and neck cancer.
 
Jean Bourhis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Debiopharm Group; Merck Serono; Merck Sharp & Dohme
 
Barbara Burtness
Consulting or Advisory Role - Aduro Biotech; ALX Oncology; Celgene; CUE Biopharma; Debiopharm Group; IO Biotech; Ipsen; Macrogenics; Maverick Therapeutics; Merck; Nanobiotix; Oncolys BioPharma; Rakuten Medical
Research Funding - Aduro Biotech (Inst); Bristol Myers (Inst); CUE Biopharma (Inst); Exelixis (Inst); Formation Biologics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Debiopharm Group; Merck
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Doxapharma; Eisai; GlaxoSmithKline; Incyte; Ipsen; Merck Serono; MSD; Nanobiotix; Novartis; Roche; SOBI
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck Serono; MSD
 
Christopher Nutting
Consulting or Advisory Role - Debiopharm Group
 
Jonathan D. Schoenfeld
Consulting or Advisory Role - ACI Clinical; Catenion; Debiopharm Group; Immunitas; LEK; Tilos Therapeutics
Research Funding - Bristol-Myers Squibb; Merck; Regeneron
Expert Testimony - Heidell, Pittoni, Murphy & Bach; Kline & Specter P.C.
 
Rafik Ait Sarkouh
Employment - Debiopharm Group
 
Florilene Bouisset
Employment - Debiopharm Group
 
Heidi Nauwelaerts
Employment - Debiopharm Group
 
Yulia Urfer
Employment - Debiopharm Group
 
Claudio Zanna
Employment - Debiopharm Group
 
Ezra E.W. Cohen
Consulting or Advisory Role - Bayer; BioNTech; Eisai; Gilead Sciences; Merck; MSD; Regeneron